Aflibercept for treating visual impairment caused by macular oedema secondary to central retinal vein occlusion

  • Technology appraisal guidance
  • TA305
  • Published: 
Download guidance (PDF)

1 Guidance

1.1 Aflibercept solution for injection is recommended as an option for treating visual impairment caused by macular oedema secondary to central retinal vein occlusion only if the manufacturer provides aflibercept solution for injection with the discount agreed in the patient access scheme.